Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details)

v3.19.3
Organization and Nature of Operations (Details)
9 Months Ended
Sep. 30, 2019
Organization and Nature of Operations (Textual)  
Percentage of Ownership 40.00%
Avalon Healthcare System, Inc. (“AHS”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation Delaware
Date of Incorporation May 18, 2015
Percentage of Ownership 100.00%
Principal Activities Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in United States of America ("USA")
Avalon (BVI) Ltd. (“Avalon BVI”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation British Virgin Island
Date of Incorporation Jan. 23, 2017
Percentage of Ownership 100.00%
Principal Activities Dormant, is in process of being dissolved
Avalon RT 9 Properties LLC (“Avalon RT 9”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation New Jersey
Date of Incorporation Feb. 07, 2017
Percentage of Ownership 100.00%
Principal Activities Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation PRC
Date of Incorporation Apr. 29, 2016
Percentage of Ownership 100.00%
Principal Activities Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in China
Genexosome Technologies Inc. (“Genexosome”) [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation Nevada
Date of Incorporation Jul. 31, 2017
Percentage of Ownership 60.00%
Principal Activities Develops proprietary diagnostic and therapeutic products using exosomes
Beijing Jieteng (Genexosome) Biotech Co., Ltd. Biotech Co., Ltd. [Member]  
Organization and Nature of Operations (Textual)  
Place of Incorporation PRC
Date of Incorporation Aug. 07, 2015
Percentage of Ownership 100.00%
Principal Activities Provides development services for hospitals and other customers and sells developed items to hospitals and other customers in China
Avactis Biosciences Inc. (''Avactis'')  
Organization and Nature of Operations (Textual)  
Place of Incorporation Nevada
Date of Incorporation Jul. 18, 2018
Percentage of Ownership 100.00%
Principal Activities Integrate and optimize global scientific and clinical resources to further advance cellular therapies, including regenerative medicine with stem/progenitor cells as well as cellular immunotherapy including CAR-T, CAR-NK, TCR-T and others to treat certain cancers
International Exosome Association LLC (''Exosome")  
Organization and Nature of Operations (Textual)  
Place of Incorporation Delaware
Date of Incorporation Jun. 13, 2019
Percentage of Ownership 100.00%
Principal Activities Promotes standardization related to exosome industry